Cargando...
Preclinical Childhood Sarcoma Models: Drug Efficacy Biomarker Identification and Validation
Over the past 35 years, cure rates for pediatric cancers have increased dramatically. However, it is clear that further dose intensification using cytotoxic agents or radiation therapy is not possible without enhancing morbidity and long-term effects. Consequently, novel, less genotoxic, agents are...
Gardado en:
| Publicado en: | Front Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4549564/ https://ncbi.nlm.nih.gov/pubmed/26380223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2015.00193 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|